Jens Kjeldsen-Kragh

Title: Jens Kjeldsen-Kragh: Innovator in Neonatal Medicine

Introduction

Jens Kjeldsen-Kragh is a notable inventor based in Eiksmarka, Norway. He has made significant contributions to the field of neonatal medicine, particularly in the treatment of neonatal alloimmune thrombocytopenia (NAIT). With a total of 2 patents, his work focuses on improving outcomes for mothers and their newborns.

Latest Patents

Kjeldsen-Kragh's latest patents include a preparation useful for, and a method for the treatment of neonatal alloimmune thrombocytopenia (NAIT). This innovative preparation aims to provide prophylactic treatment for women post-childbirth to prevent immunization and antibody production that could lead to NAIT and fetal/neonatal bleeding in subsequent pregnancies. The method involves administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.

Career Highlights

Throughout his career, Jens has worked with various companies, including Prophylix Pharma and Tto Nord. His experience in these organizations has allowed him to develop and refine his innovative approaches to neonatal care.

Collaborations

Some of his notable coworkers include Bjorn Ragnar Skogen and Anne Husse-Bekk. Their collaboration has contributed to the advancement of research and development in the field of neonatal medicine.

Conclusion

Jens Kjeldsen-Kragh is a dedicated inventor whose work in neonatal medicine has the potential to significantly improve the health and well-being of mothers and their children. His innovative patents and collaborations reflect his commitment to advancing medical science.